Matt Hedrick, Chief Executive Officer
Jeff Shepherd, Vice President of Sales
Nanovis is a unique technology company that discovers, develops, and commercializes innovative nanotechnology platforms designed for improving bone growth and fighting infection. Nanovis’s bioceramic nanotube surface is FDA cleared with a differentiated label, is well-proven and is ready to upgrade any orthopedic implant made of titanium or titanium alloy. Nanovis’s Nano FortiCore interbodies also utilize a deeply porous titanium scaffold (licensed from Sites Medical). Nanovis’s advanced bioceramic bactericidal nanotube surface technology and Nanovis’s breakthrough localized infection technology targeting multi drug resistant bacteria is in pre-clinical studies.